5th Annual MarketsandMarkets Neuroscience R&D Technologies Conference

3rd - 4th October 2019 | Radisson Blu Edwardian, Grafton Hotel, London
CONFERENCE SPEAKERS
Advisors
Georg Terstappen
Georg Terstappen
Chief Scientific Officer,
OxStem



Frank Hirth
Frank Hirth
Group Leader Neural Circuits and ,
Behaviour King’s College London, UK


Frank Hirth is Reader of Evolutionary Neuroscience at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. He received his PhD in Zoology at the University of Basel in Switzerland and trained in neurogenetics at the universities of Freiburg, Basel and the MRC National Institute for Medical Research in London. During his time at the Institute of Zoology in Basel, he discovered evolutionarily conserved genetic mechanisms underlying insect and mammalian brain development. Currently at King’s his lab investigates how neural circuits form and function, especially central brain circuits that coordinate voluntary behaviour. In an evolutionary approach, his team applies their insights to elucidate pathogenic mechanisms underlying cell and circuit dysfunction that lead to synaptopathies including Parkinson's and Motor Neurone Disease, as well as Frontotemporal Dementia.


Speakers
Shailendra Singh (Shelly)
Shailendra Singh (Shelly)
Chief Operating Officer,
MarketsandMarkets


Shailendra Singh (Shelly) is Chief Operating Officer of MnM and a member of its board. He focuses on global sales and client services functions, as well as commercial optimization at MarketsandMarkets. He has years of expe¬rience in global delivery and outsourcing sector in the IT/ Consulting/Analytics/Big Data sectors. Prior to MnM, he was leading the global sales, client services and commercial ef¬fectiveness functions for Mu Sigma, a unicorn company and a leading global provider of Decision Sciences and Big Data analytics solutions.


Georg Terstappen
Georg Terstappen
Chief Scientific Officer,
OxStem



Arshad	Majid
Arshad Majid
Professor of Cerebrovascular Neurology, Director, Comprehensive Cerebrovascular Research unit (CCRU),
University of Sheffield



Frank Hirth
Frank Hirth
Group Leader Neural Circuits and ,
Behaviour King’s College London, UK


Frank Hirth is Reader of Evolutionary Neuroscience at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. He received his PhD in Zoology at the University of Basel in Switzerland and trained in neurogenetics at the universities of Freiburg, Basel and the MRC National Institute for Medical Research in London. During his time at the Institute of Zoology in Basel, he discovered evolutionarily conserved genetic mechanisms underlying insect and mammalian brain development. Currently at King’s his lab investigates how neural circuits form and function, especially central brain circuits that coordinate voluntary behaviour. In an evolutionary approach, his team applies their insights to elucidate pathogenic mechanisms underlying cell and circuit dysfunction that lead to synaptopathies including Parkinson's and Motor Neurone Disease, as well as Frontotemporal Dementia.


Emer Leahy
Emer Leahy
CEO ,
Psychogenics



Winston Hide
Winston Hide
C0-Director Non-Coding RNA Core,
Harvard University



Yang (Ted) Teng
Yang (Ted) Teng
Director, Laboratory of SCI, Stem Cell & Neurofacilitation Research,
Harvard University



Mark Tricklebank
Mark Tricklebank
Wellcome Trust Research Fellow, Neuroimaging,
King’s College London, UK



David Taggart
David Taggart
Chief Operating Officer,
Glycyx Therapeutics, USA



Silvia Cainarca
Silvia Cainarca
Principal Investigator, Project Leader,
IMI2 project -NGN-PET, Italy



Kei Cho
Kei Cho
Honorary Chair of Neuroscience,
University of Bristol, UK



Vlad Veklych
Vlad Veklych
Director, European Business Development,
Biorasi, Germany



Paul Karila
Paul Karila
CSO,
Cellectricon



Nicholas Clare
Nicholas Clare
Head, Customer Solutions,
Axol Bioscience



Isabella Premoli
Isabella Premoli
Research Lead,
The Science Behind


Isabella graduated in Pharmacy from the University of Pavia (Italy) and pursued a Ph.D. in Behavioural Neuroscience at the University Hospital of Tübingen (Germany) in collaboration with the International Max Planck Research School. Her PhD focused on the investigation of GABAergic neurotransmission by combining TMS and EEG under the administration of drugs with well-known modes of action. In 2014, after joining the Richardson Lab at King’s College London, she established a new TMS-EEG facility within King’s College Hospital. 

Her work showed that TMS-EEG can measure GABA-mediated processes and the pharmacological effects of several drugs acting in the human brain. She incorporated TMS-EEG in first-in-human clinical trials of new anti-epileptic drugs to obtain pharmacodynamic readouts of drug activity. Her research aims to develop TMS-EEG predictors and markers of treatments and of the pathophysiology of brain disorders.

 


Michela Chiappalone
Michela Chiappalone
Team Leader,
Italian Institute of Technology



Olaf Schroder
Olaf Schroder
CEO,
Neuroproof, Germany



Steven 	Biesmans
Steven Biesmans
Senior Scientist,
UCB



Xiao Xu
Xiao Xu
Co-Founder,
Cerevance, UK



Noelle Callizot
Noelle Callizot
Co-Founder, CSO,
Neuro-Sys



Mufti Mahmud
Mufti Mahmud
Senior Lecturer, Computing & Technology,
Nottingham Trent University,